Susvimo is also approved to treat age-related macular degeneration, and the medication, ranibizumab, is delivered though a ...

The Louisiana Republican, who led a hepatitis B vaccination campaign before entering politics, has expressed concerns about ...

In a partisan vote, the Senate Finance Committee voted to forward the nomination of Robert F. Kennedy Jr. as HHS Secretary to the full Senate ...

This follows the company’s recent earnings call, where executives discussed the organization’s growth and future plans, ...

Potential threats to HIV care and fallout over the next four years, according to Jose Abrigo, Esq., HIV project director at ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Much of the association between trauma and suicide risk among university students can be explained by shame, a new study ...

Becky Kamowitz was appointed executive director of The Skin Cancer Foundation in January 2025. She talks about organization’s ...

The new biosimilar, Celltrion’s Avtozma, was approved in both IV and subcutaneous forms to treat inflammatory conditions such as arthritis.

The HYPERION study was evaluating Winrevair in recently diagnosed adults with pulmonary arterial hypertension.

The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid ...

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...